StocksFin Logo
ACADIA Pharmaceuticals Inc. country of incorporation
|
|
Mr. Stephen Davis
|
510 employees
NASDAQ | Healthcare | Biotechnology
Axonics, Inc. country of incorporation
|
|
Mr. Raymond Cohen
|
517 employees
NASDAQ | Healthcare | Medical Devices
Q322 reported Nov 3, 2022 Reporting Period
$130.71M -0.7% vs. Q321 Revenues Q322
98.37% 3.6% vs. Q321 Gross Profit Margin
-20.8% ! -89.3% vs. Q321 Net Profit Margin
-727k ! 95.7% vs. Q321 Free Cash Flow Q322
$-0.17 ! -88.9% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Nov 9, 2022 Reporting Period
$70.38M 50% vs. Q321 Revenues Q322
72.83% 9.5% vs. Q321 Gross Profit Margin
-23.09% ! 37.2% vs. Q321 Net Profit Margin
2.88M 196.3% vs. Q321 Free Cash Flow Q322
$-0.34 ! 10.5% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
4.23
6.36
Current Ratio
4.47
7.39
Cash Ratio
1.33
3.97
Price to Book
6.22
6.05
Price to Sales
20.26
47.25
Price to Earnings
-24.35
-51.15